Search
Menu
Excelitas Technologies Corp. - X-Cite Vitae LB 11/24

Dynasil Biomedical Begins Operation

Facebook X LinkedIn Email
WATERTOWN, Mass., April 15, 2011 — Dynasil Corp. of America has announced the incorporation of a new business unit to pursue opportunities in the biomedical field. Located in Rochester, Minn., Dynasil Biomedical Corp. has hired Dr. Daniel Ericson as its scientific lead with responsibility for research and development. The company purchased for $300,000 Ericson’s rights to six biomedical technologies invented or co-invented by him, as well as certain rights to royalties and milestone payments if the technologies are successfully developed. Prior to Dynasil Biomedical, Ericson worked at the Mayo Clinic. Several...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: April 2011
    Americasbiomedical technologiesBiophotonicsblood coagulationBusinesscardiovascular risksDaniel EricsonDynasil Biomedical Corp.Dynasil Corporation of AmericahemophiliaImagingMassachusettsMayo ClinicMinnesotaoptical detection systemspoint-of-care diagnosticsRMD InstrumentsRMD Researchtissue sealanttuberculosis test

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.